(Q35111932)

6 August 2017

title

Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells (English)

1 reference

6 August 2017

1 reference

Seogkyoung Kong

1

1 reference

6 August 2017

Sadhak Sengupta

2

1 reference

6 August 2017

Betty Tyler

3

1 reference

6 August 2017

Anthony J Bais

4

1 reference

6 August 2017

Qiangzhong Ma

5

1 reference

6 August 2017

Saryn Doucette

6

1 reference

6 August 2017

Jinyuan Zhou

7

1 reference

6 August 2017

Ayguen Sahin

8

1 reference

6 August 2017

Bob S Carter

9

1 reference

6 August 2017

Henry Brem

10

1 reference

6 August 2017

Richard P Junghans

11

1 reference

6 August 2017

Prakash Sampath

12

1 reference

6 August 2017

language of work or name

English

0 references

publication date

10 September 2012

1 reference

6 August 2017

published in

Clinical Cancer Research

1 reference

6 August 2017

volume

18

1 reference

6 August 2017

issue

21

1 reference

6 August 2017

page(s)

5949-5960

1 reference

Inducible apoptosis as a safety switch for adoptive cell therapy

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Is it safer CARs that we need, or safer rules of the road?

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Anti-GD3 chimeric sFv-CD28/T-cell receptor zeta designer T cells for treatment of metastatic melanoma and other neuroectodermal tumors

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Genetically engineered T cells to target EGFRvIII expressing glioblastoma

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

The promise and potential pitfalls of chimeric antigen receptors

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Second-generation anti-carcinoembryonic antigen designer T cells resist activation-induced cell death, proliferate on tumor contact, secrete cytokines, and exhibit superior antitumor activity in vivo: a preclinical evaluation

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Sorting vector producer cells for high transgene expression increases retroviral titer

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Cancer regression in patients after transfer of genetically engineered lymphocytes

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Adoptive transfer of gene-engineered CD4+ helper T cells induces potent primary and secondary tumor rejection

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Characterization of the interaction between interleukin-13 and interleukin-13 receptors

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Interleukin 13 mutants of enhanced avidity toward the glioma-associated receptor, IL13Ralpha2

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Quantifying signaling-induced reorientation of T cell receptors during immunological synapse formation

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Mutation and functional analysis of IL-13 receptors in human malignant glioma cells

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Characterization of a powerful high affinity antagonist that inhibits biological activities of human interleukin-13

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

cDNA cloning and characterization of the human interleukin 13 receptor alpha chain

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

The law of mass action governs antigen-stimulated cytolytic activity of CD8+ cytotoxic T lymphocytes

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

CD28 cosignalling does not affect the activation threshold in a chimeric antigen receptor-redirected T-cell attack

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Patterns of care for adults with newly diagnosed malignant glioma.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

Novel anti-brain tumor cytotoxins specific for cancer cells

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4337849

T lymphocyte costimulation mediated by reorganization of membrane microdomains

27 September 2018

1 reference

PubMed

12 December 2020

Chimeric receptors providing both primary and costimulatory signaling in T cells from a single gene product

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

A role of interferon-gamma (IFN-gamma) in tumor immunity: T cells with the capacity to reject tumor cells are generated but fail to migrate to tumor sites in IFN-gamma-deficient mice

1 reference

PubMed

12 December 2020

10.1158/1078-0432.CCR-12-0319

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference